SAM
EPIX

Sectoral Asset Management’s ESSA Pharma EPIX Stock Holding History

Sectoral Asset Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-331,963
Closed -$9.48M – 131
2021
Q2 		$9.48M Sell
331,963
-40,000
-11% -$1.16M 0.77% 57
2021
Q1 		$10.8M Buy
+371,963
New +$8.65M 0.82% 53

Other funds holding EPIX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Sectoral Asset Management's EPIX Position: Q3 2021 in Review

Sectoral Asset Management sold out of ESSA Pharma (EPIX) in Q3 2021, closing a stake of 331,963 shares — an estimated $9.48M sold.

Sectoral Asset Management first reported a position in EPIX in Q1 2021 and held it in 2 quarters. The position peaked at $10.8M in Q1 2021. 75 funds tracked by Wall St. Rank hold EPIX as of Q3 2021.

  • Sectoral Asset Management reported no remaining ESSA Pharma position as of Q3 2021 after selling out during the quarter.
  • Sectoral Asset Management sold 331,963 ESSA Pharma shares in Q3 2021, an estimated $9.48M.
  • Sectoral Asset Management first reported a position in ESSA Pharma in Q1 2021 and held it in 2 quarters.
  • Sectoral Asset Management's ESSA Pharma position peaked at $10.8M in Q1 2021.
  • 75 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2021.

Based on Sectoral Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.